Abbott Laboratories (ABT) operating KPIs
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)
Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%
Latest, FY2025
23,327
Period ended Dec 31, 2025
Change on a year earlier
+9.2%
21,366 in FY2024
History
12 years
Since FY2014
Sources
11
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | GAAP Gross Margin ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 23,327 | +9.2% | SEC Filing (0001628280-26-002982) ↗ |
| FY2024 | Dec 31, 2024 | 21,366 | +5.9% | SEC Filing (0001628280-26-002982) ↗ |
| FY2023 | Dec 31, 2023 | 20,168 | -10.4% | SEC Filing (0001628280-25-002092) ↗ |
| FY2022 | Dec 31, 2022 | 22,498 | 0.0% | SEC Filing (0001628280-24-002009) ↗ |
| FY2021 | Dec 31, 2021 | 22,491 | +28.7% | SEC Filing (0001628280-23-001516) ↗ |
| FY2020 | Dec 31, 2020 | 17,473 | +4.4% | SEC Filing (0001104659-22-007648) ↗ |
| FY2019 | Dec 31, 2019 | 16,737 | +6.6% | SEC Filing (0001104659-21-007942) ↗ |
| FY2018 | Dec 31, 2018 | 15,694 | +20.7% | SEC Filing (0001104659-20-005717) ↗ |
| FY2017 | Dec 31, 2017 | 13,006 | +15.3% | SEC Filing (0001104659-19-002848) ↗ |
| FY2016 | Dec 31, 2016 | 11,279 | +2.0% | SEC Filing (0001104659-18-003691) ↗ |
| FY2015 | Dec 31, 2015 | 11,057 | +5.6% | SEC Filing (0001104659-17-003920) ↗ |
| FY2014 | Dec 31, 2014 | 10,474 | – | SEC Filing (0001104659-16-091861) ↗ |
Cite this data
StockData. (2026). Abbott Laboratories GAAP Gross Margin ($M) ($M), annual FY2014–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/db-is-gm-gaap
See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.